Abstract
Chronic respiratory infection with Burkholderia cenocepacia (Bc) in patients with cystic fibrosis (CF) is associated with accelerated decline in lung function and increased mortality. It is therefore important to attempt to eradicate new isolates, especially in children. However, there are no standardized guidelines to eradicate Bc. We report a case of successful eradication of new isolates of Bc in a 2-year-old child with CF using a combination of IV, nebulized antibiotics and sinus surgery.
Keywords:
Burkholderia cenocepacia; cystic fibrosis; sinus surgery.
MeSH terms
-
Administration, Inhalation
-
Administration, Oral
-
Anti-Bacterial Agents / therapeutic use*
-
Burkholderia Infections / complications
-
Burkholderia Infections / therapy*
-
Burkholderia cenocepacia / isolation & purification*
-
Child, Preschool
-
Cystic Fibrosis / complications*
-
Humans
-
Levofloxacin / therapeutic use
-
Male
-
Maxillary Sinus / surgery
-
Maxillary Sinusitis / complications
-
Maxillary Sinusitis / therapy*
-
Meropenem / administration & dosage
-
Nasal Lavage
-
Otorhinolaryngologic Surgical Procedures*
-
Penicillins / administration & dosage
-
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Penicillins
-
temocillin
-
Levofloxacin
-
Trimethoprim, Sulfamethoxazole Drug Combination
-
Meropenem